Objective: To determine whether mutations in the gene for FSHbeta are
present, and possibly etiologic, in some patients with 46,XX premature
ovarian failure (POF). Design: DNA samples obtained from 18 study pat
ients with POF and two menopausal fertile controls were studied by Sou
thern blot analysis. DNA sequencing was performed in one patient. Sett
ing: Patients were seen in a reproductive endocrinology clinic and stu
died in a medical school laboratory setting at the Medical College of
Georgia and Tufts University. Main Outcome Measures: Restriction fragm
ent sizes on autoradiographs were compared between the study group and
controls. DNA sequencing radiographs were compared between one study
patient and five controls. Results: Fragment sizes obtained with the r
estriction enzymes EcoRI, DraI, HincII, PstI, KpnI, BglI, BamHI, and B
glII were similar size in both study subjects and controls using the p
robes pFSHbeta-1.4 and pFSHbeta-1.2. A previously described HindIII po
lymorphism was present using pFSHbeta-1.2, but HindIII fragment sizes
were identical in patients with ovarian failure and controls using pFS
Hbeta-1.4. DNA sequencing of the FSHbeta gene in one patient was norma
l. Conclusions: No mutations in the gene for FSHbeta were identified i
n women with POF. DNA sequencing of the exons and promoter region of t
he FSHbeta gene in one woman with POF was normal. This does not entire
ly exclude the possibility that smaller deletions, insertions, or poin
t mutations of the FSHbeta could be etiologic in some women with POF.
The HindIII polymorphism does not appear to segregate with 46,XX POF.